NCT04938453View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Four Capsules of 25 mg Nintedanib Are Taken up in the Body in the Same Way as One 100 mg Capsule

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions
Healthy
Interventions
DRUG

nintedanib 25 mg

soft gelatin capsule

DRUG

nintedanib 100 mg

soft gelatin capsule

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04938453 - A Study in Healthy Men to Test Whether Four Capsules of 25 mg Nintedanib Are Taken up in the Body in the Same Way as One 100 mg Capsule | Biotech Hunter | Biotech Hunter